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 Abstract 
A stochastic model was designed to calculate the cost-effectiveness of biosecurity strategies for 
Bovine Viral Diarrhea Virus (BVDV) in cow-calf herds.  Possible sources of BVDV introduction 
considered were imported animals, including the calves of pregnant imports, and fenceline 
contact with infected herds, including stocker cattle raised in adjacent pastures.  Spread of 
BVDV through the herd was modeled with a stochastic SIR model.  Financial consequences of 
BVDV, including lost income, treatment costs, and the cost of biosecurity strategies, were 
calculated for 10 years, based on the risks of a herd with a user-defined import profile.  Results 
indicate that importing pregnant animals and stockers increased the financial risk of BVDV.  
Strategic testing in combination with vaccination most decreased the risk of high-cost outbreaks 
in most herds.  The choice of a biosecurity strategy was specific to the risks of a particular herd. 
 
1 Introduction 
 Bovine viral diarrhea virus (BVDV) costs the beef industry through decreased production 
and increased expenses (Wittum et al., 1994; Gunn et al., 1998; Bennett et al., 1999; Larson et 
al., 2002).  It is a common disease in the US cattle herd (Houe et al., 1995; Paisley et al., 1996; 
Chase et al., 2003).   
Fetal infection between 40 and 125 days gestation can lead to a persistently infected 
animal (PI) (Stokstad and Loken, 2002), which will shed virus for life through oculonasal 
discharges (Confer et al., 2005).  Persistently infected animals are generally considered to be the 
primary source of BVDV introduction to a herd (Houe, 1999; Niskanen et al., 2002). 
Animals with transient infections (TIs), caused by exposure to BVDV while not in the 
risk period to become PI, experience a range of negative effects.  In adults, these are mostly 
reproductive disorders,
 
such as abortion (Fredriksen et al., 1998), decreased conception risk 
(Houe and Meyling, 1991; McGowan et al., 1993a; McGowan et al., 1993b; Larsson et al., 1994; 
Wittum et al., 2001), early embryonic death (EED) (McGowan et al., 1993a; McGowan et al., 
1993b), and congenital defects (Munoz-Zanzi et al., 2003; Ellsworth et al., 2006).  In calves, 
common symptoms include immunosuppression leading to increased morbidity and mortality 
(Castrucci et al., 1992; Bjorkman et al., 2000; Kozasaa et al., 2005). 
Biosecurity against BVDV introduction includes testing imported animals, vaccinating 
against BVDV, testing-and-culling programs of the resident herd, and avoiding potentially 
infectious contact with infected herds, especially PI animals.  Testing strategies on imported 
animals aim to reduce the number of PIs introduced to a herd and may be cost effective (Stott et 
al., 2003).  Vaccination is meant to decrease the spread of the virus once it is introduced to the 
herd; specifically, it is intended to prevent the birth of new PIs.  Test-and-cull programs, often 
focusing on calves, are used to decrease the number of PIs present in an infected herd.  This is 
commonly done before the breeding season to decrease the number of sources of infection 
present during the risk period (days 45-180 of gestation) for producing more PIs.  In addition to 
these strategies, avoiding contact with other cattle herds at fencelines and in communal pastures 
may also prevent herd infection (Valle et al., 1999). 
A multitude of stochastic models have been developed to study the effects of BVDV 
control programs on dairy herds (Innocent et al., 1997a; Innocent et al., 1997b; Cherry et al., 
1998; Viet et al., 2004a; Viet et al., 2004b; Viet et al., 2005; Viet et al., 2006; Ezanno et al., 
2007).  Management differences between dairy and beef operations, however, make those 
models less helpful in decision making for cow-calf producers.  In particular, the limited 
breeding season of beef herds limits the risk period for the creation of PI animals.  This limited 
breeding season also increases the risk to the herd during this time period, as a greater proportion 
of dams will be in the risk period at one time compared to a dairy, when breeding is usually 
spread over the course of a year.  Also, testing strategies in dairy herds often include monitoring 
of the bulk milk tank, which is not possible in beef herds.  In addition, the spread of the virus is 
affected by the lower animal density of pastured beef herds, compared to intensively managed 
dairies, and by the continued contact between calves and adults until weaning in beef herds.  
One previous model has been developed for BVDV in a cow-calf herd (Cleveland, 2003).    
This model was designed to examine the effect of test-and-cull strategies in an endemically 
infected cow-calf herd.  While this model is quite useful for the closed, infected herd aiming to 
control the infection, it does not address the effectiveness of biosecurity strategies in herds not 
currently infected.  It also does not provide estimates of cost-effectiveness, which are necessary 
for producers to make informed biosecurity decisions.  One partial budget analysis examined the 
efficacy of testing for BVDV in incoming feedlot calves (Larson et al., 2005), but management 
factors again make the results less applicable to cow-calf operations.  No models that are 
available in the literature address the overall impact of all BVDV control strategies within cow-
calf herds, although Nickell et al. (2011) do consider the value of different whole-herd testing 
strategies.  We have previously developed risk analysis models for the introduction (Smith et al., 
2009) and within-herd spread (Smith et al., 2010) of BVDV for cow-calf herds.  The purpose of 
this study was to develop a stochastic risk-analysis model, using the existing models for the 
introduction and spread of BVDV in cow-calf herds, to determine the cost-efficacy of control 
and the total cost of BVDV in US cow-calf herds. 
2 Materials and Methods  
 This paper describes the integration of three Monte Carlo simulation models: a model for 
the annual introduction risk for BVDV to a cow-calf herd and the impact of biosecurity strategies 
(Smith et al., 2009), a model for the effects of BVDV over 10 years after introduction to a naïve 
cow-calf herd and the impact of control strategies on those effects (Smith et al., 2010), and a 
model for the economic costs of BVDV effects, biosecurity, and control.   
The first two models have been described previously.  Briefly, the introduction model 
was a Monte Carlo model in which the probability of introducing BVDV to a herd in any year 
was calculated based on two risk categories, imports and fenceline contact (Smith et al. 2009).  
The number of PIs imported to the herd was based on the number of animals imported in a given 
age category and/or pregnancy status, the PI prevalence in that age group, including fetal 
prevalence for calves of pregnant imports, and the testing strategy to prevent PI importation.  
Infection through fenceline contact was modeled based on the presence of BVDV in the adjacent 
herd and the probability of infectious contact with that herd, leading to a dichotomous variable 
for infection from fenceline contact.  The adjacent herd in this model consists of imported 
stockers (young animals grazed on available pasture for later sale to feedlots or finishers).  These 
introductions (importation of PIs and fenceline infection) were calculated independently for each 
of 10 years based on the import profile and management of the herd. 
 The model for the spread and effects of BVDV (Smith et al 2010) was driven by the 
introduction of a single PI calf imported in year 1.  Infection in the herd was tracked using a 
modified Reed-Frost (SIR) model based on the number of animals in the herd, the number of PIs 
in the herd, and the number of susceptible animals.  This discrete-time model uses 3-week 
periods, in which conception was also modeled, allowing calculation of infections during the risk 
period for fetal persistent infection.   
 The model reported here integrates both the probability of PIs from outside introduction 
and from endemic infections.  In each year, the number of PIs produced during the previous 
year’s breeding season was added to the herd in the 3-week period of the calving season 
corresponding to their date of conception.  PI calves may be removed from the herd each year by 
a pre-breeding test-and-cull strategy. When infection occurred by fenceline contact, the presence 
of a single PI crossing into the herd was added to the Reed-Frost calculation for a single 3-week 
time period to represent cross-fence contact.   
 The number of PI mortalities was calculated for each 3-week period, allowing the PIs to 
be removed from the herd at death.  The number of PI morbidities, however, was based on the 
number of PIs present on an annual basis, as morbidity in PI cattle does not impact the risk to 
spreading infections in the herd.  All other effects of BVDV were also modeled on an annual 
basis, based on the number of infections in each risk group within the herd.  The number of 
abortions was based on the number of pregnant females exposed to infection during the 
appropriate time period, while the numbers of TI morbidities and mortalities were based on the 
number of infected calves on an annual basis.  The number of EEDs and congenital defects were 
calculated based on the number of infections during their respective risk periods, as were the 
number of PIs to be born.  EEDs occurring before the end of the breeding season, at which time 
the dams were allowed to rebreed, were distinguished from EEDs occurring after the breeding 
season has ended and rebreeding was no longer possible.   
 Vaccination was modeled on an annual basis, removing a proportion of the breeding 
females (determined by the vaccine efficacy) from the susceptible category for a single year.  
Vaccinated or otherwise immune animals were assumed to give birth to immune calves, which 
were assumed to remain immune until weaning. 
 The economic model for the total 10-year cost of BVDV in cow-calf herds was based on 
a partial budget, integrating management costs and lost income.  Parameters used to estimate 
performance in this model are described in Table 1.  Annual inputs from the introduction risk 
and herd spread models were used to calculate the cost of BVDV for that year.  Economic 
impacts (cost) were based on both treatment cost (based on the number of calf morbidities) and 
lost income due to decreased performance.  Total lost income was calculated as the price per 
kilogram times the difference between estimated performance in diseased and non-diseased 
animals.  Price per kilogram was modeled on a draw of historical prices for the month of 
September from a 10-year period (2003-2012).  The decreased weaning weight was the sum of 
the decrease in weaning weight due to BVDV in morbid calves and the total weight of calves lost 
to BVDV mortality.  Decreased weaning weights were also calculated for calves based on the 
number of EEDs occurring in cows that successfully rebred before the end of the breeding 
season, as these would result in younger (and consequently lighter) calves at weaning.  Calf 
mortality was the sum of the number of abortions, EEDs in cows that failed to rebreed, 
congenital defects, TI mortalities, and PI mortalities.  The possible weaning weight of those lost 
calves was based on a binomial calculation for the numbers of heifers and steers that were lost 
and on the weaning weight distribution for each gender.   
The stochastic model was developed with @Risk 6.1 (Palisade Corp, Ithaca, NY), an 
add-in for Excel® 2010 (Microsoft Corp, Redmond, WA). 
2.1 Validation 
 Validation of the model disease outputs was performed in Smith et al. (2010) using two 
published outbreaks involving 4 cow-calf herds in which the source of the virus could be inferred 
(Taylor et al. 1994;VanCampen et al., 2000).  No published economic outcome is available to 
directly validate the economic outcomes of the model.  
Taylor et al. (1994) reported data for 3 years following the recognition of the outbreak.  It 
was modeled as a 200 cow herd with 1 PI fetus introduced in year 1.  Calf morbidity, mortality 
and endemic PI’s produced were reported and compared to model output.  VanCampen et al. 
(2000) reported data for 1 year on 3 herds of 250 cows, 340 cows and 285 cows.  Each herd was 
modeled with the introduction of 1 PI calf in year 1.  Calf mortality and number of abortions 
were reported and compared to model output.  
For each outbreak validation, the simulation was run for 3000 iterations and the median 
and 95% prediction interval for each of the categories observed were calculated.  Model output 
and 95% prediction intervals were compared to the observed values. 
2.2 Model Application 
 A range of possible herd profiles is described in Table 2, and a variety of biosecurity 
strategies is listed in Table 3.  The model was run for 3000 iterations with a fixed random 
number seed for each of the possible herds listed with each of the listed biosecurity strategies 
appropriate to that herd.  Calculated costs included the cost of disease and the cost of prevention 
and treatment for each simulation.  The median and 95% prediction intervals for total 10-year 
cost were collected from the model.  Stochastic dominance graphs were generated for each herd 
with all biosecurity strategies.   
Investigation of the probability of exceeding a target value for the 10-year cost of BVDV 
in the herd, accounting for both the cost of disease and the cost of prevention, was performed 
using target analysis as a means of quantifying economic risk for each herd scenario.  This 
involved determining the proportion of iterations in which the total 10-year cost was at least the 
target value, indicating the probability of the herd spending at least as much as the target on 
BVDV over a 10-year period.  The optimal (dominant) control strategy would have the lowest 
probability of exceeding the specified target cost; if probabilities of exceeding the target cost for 
more than one strategy were not significantly different, those strategies would be considered co-
dominant. The target values were set as $40,000 for a 400-head herd, $7,500 for a 100-head 
herd, and $2,500 for a 50-head herd.  These values were selected to represent the average return 
to labor and management for each respective cow-calf herd size for ten years (USDA:ERS, 
2012), taking into account economies of scale and size. These values represent a severe loss to 
the enterprise that could jeopardize business continuity and that nearly all enterprises would want 
to minimize. All scenario distributions for the probability of exceeding the target value met the 
criteria for a normal approximation (np and n(1-p) >5) so 95% confidence intervals around the 
probability of exceeding the target were calculated based on the normal approximation for the 
binomial distribution.  Probabilities were considered significantly different if the 95% confidence 
intervals did not overlap. 
2.3 Sensitivity analysis  
A global sensitivity analysis was performed on the model to determine the importance of 
the parameter distributions listed in Table 1.  Sensitivity analyses on the introduction and the 
spread models have been previously reported (Smith et al. 2009, Smith et al. 2010).  The 
sensitivity analysis results for the integrated economic model reported here were produced with 5 
biosecurity scenarios for a 400-head herd importing 60 pregnant heifers, 4 bulls, and 100 
stockers.  The biosecurity and control scenarios were M (using no biosecurity or control 
program), N (vaccinating all adult animals), T (testing all imported animals, including stockers 
and calves of pregnant heifers), Y (testing all imported animals, including calves of pregnant 
heifers but excluding stockers, and vaccinating all adult animals), and Z (testing all imported 
animals, including stockers and calves of pregnant heifers, and vaccinating all adult animals).  
These scenarios represent a mixed selection of the scenarios presented in the model results, 
including the scenario with the lowest mean cost (Y) and the scenario with the lowest probability 
of exceeding the target (Z).   
A local sensitivity analysis was also performed on the 5 scenarios for each parameter 
whose correlation coefficient was statistically significant in the global sensitivity analysis for at 
least one scenario. For each scenario, the mean 10-year cost of BVDV was determined with each 
of the parameters of interest fixed individually at the 5
th
 and 95
th
 percentiles, as listed, for 3000 
iterations of the model with a fixed number seed.  This allowed the sensitivity analysis to 
determine the impact of each distribution within approximately 90% of its expected range.  
Differences between the low and high values for cost were calculated and reported as proportions 
of the mean cost of the scenario in the base model. 
3 Results 
3.1 Validation 
Validation of disease outputs are reported in Smith et al. (2010).   
3.2 Model Application 
Three thousand was a sufficient number of iterations for mean, standard deviation, and 
percentiles of all outputs in all simulations to converge within 5%.  In none of the simulations 
were there significant differences between the mean costs of any biosecurity strategy, based on 
comparison of 95% confidence intervals (data not shown).  First-order stochastic dominance was 
not observed for any strategy, regardless of herd size.  Two examples of cumulative probability 
graphs demonstrating the variation in costs are provided in Figure 1. 
The results of the target analysis are presented in Table 4; dominant or co-dominant 
strategies based on non-overlapping 95% PI’s are in bold type for each column.  The median and 
95% prediction intervals of 10 year costs are presented in Table 5 for all herd and strategy 
combinations. 
3.3 Sensitivity Analysis 
The correlation coefficients from a global sensitivity analysis for all input parameters are 
shown in Table 6 for all scenarios analyzed.  For a herd with no control or biosecurity (M) or a 
herd relying only on vaccination (N), the most significant parameters were the abortion risk, calf 
sale prices, and the TI mortality risk; an increase in any of these parameters increased the mean 
10-year cost of BVDV.  The herd relying only on vaccination also experienced lower costs when 
vaccine efficacy was increased.  In any herd relying on testing, the cost of the test was the most 
significant parameter.  When vaccination was added to testing, the cost of vaccination was also 
significant.  The proportional difference in mean cost from a local sensitivity analysis is shown 
in Table 7 for all parameters found to be significant in the global sensitivity analysis.  This is the 
difference in mean cost when the parameter is fixed at its upper value from when the parameter 
is fixed at its lower value, divided by the mean cost when all parameters are allowed to vary; a 
positive value indicates that increasing the parameter’s value will increase the mean cost of 
BVDV, while a negative value indicates that increasing the parameter’s value will decrease the 
mean cost of BVDV. 
 
4 Discussion 
The model presented here predicts the economic risks associated with specific 
management decisions, including the importation of different classes of cattle and different 
biosecurity and control strategies related to BVDV.  While the model does not predict, in a 
deterministic sense, the most cost-effective strategy for BVDV, it does give herd-specific risk 
calculations that can assist in decision making, allowing the individual producer to include their 
individual degree of risk aversion into the decision making process.  The outcome utilized was 
based on the probability of exceeding a target value of cost, accounting for both the costs of 
disease and prevention.  This allows decision making based on the cost of disease and the cost 
and effectiveness of mitigation. 
Validation of a stochastic disease model with field data is an accepted method 
(Cleveland, 2003; Viet et al., 2004a).  However, most field data were either available from 
endemically infected herds, for which this model was not designed, or from outbreaks in which 
the source of virus is uncertain.  Validation of this model has been previously reported (Smith et 
al., 2010) using two published outbreak reports.   The model was able to predict the observations 
available for each herd within the stochastic framework that was not substantially different from 
the observed value.  The economic results reported here are a direct extension of the production 
parameters validated in the previous report.  
The predictions of the model regarding cost showed no significant differences between 
biosecurity strategies in mean cost of BVDV over 10 years in 100 and 50 head herds or in 400 
head herds importing pregnant heifers, and no first-order stochastic dominance in descending 
probability cost distributions regardless of the scenario modeled.  This was due to the low 
prevalence of PIs resulting in introduction of a PI being a rare event.  With a rare outcome, the 
mean cost of the disease is skewed to the left (lower end), obscuring differences in control 
programs.  This was the primary motivation for building a stochastic model for BVDV, so these 
results were expected. 
As means were similar and first-order dominance did not occur, decisions may need to be 
made based on alternative risk calculations.  The results presented here, based on the probability 
of exceeding a target value, are one alternative method of risk-based decision making.  Target 
analysis is an intuitive method for decision making in cow-calf production enterprises, providing 
a single probability estimate of downside risk for decision making.  
It can be seen in Table 4 that herd size and import profile were important determinants in 
the risk of exceeding the target cost.  Based on non-overlapping 95% prediction intervals herds 
importing pregnant heifers had a significantly higher probability of exceeding the target cost than 
herds importing non-pregnant heifers if no biosecurity strategy was employed (strategy M).   
Testing adult imports only (strategy O) decreased risk compared to doing nothing (strategy M) 
only in herds importing non-pregnant heifers, and was never co-dominant.  Pregnant heifers may 
be PI and carrying a PI calf, but alternatively they may be non-PI but were transiently infected 
during the risk period and carrying a PI calf.  This highlights two important considerations: 1) 
importing a pregnant heifer brings in two animals at risk for PI status, and 2) even in import 
testing strategies, it is impossible to test fetal status and the fetus is in a higher risk category for 
being PI.  A testing strategy that only tests the replacement heifers would miss the PI calf of a 
non-PI heifer and allow introduction of BVDV to the herd.  Conversely, testing the calves of 
pregnant imports after birth and before the breeding season will allow detection of the calf and 
identification of the dam for further testing.  In this model, representing best practices, the dams 
of positive calves were always tested and the calves of positive dams were automatically 
removed.  Calves and fetal imports were at proportionately greater risk to the herd than their 
dams due to the higher PI prevalence in younger animals.   
Regardless of the other import decisions, importing stockers increased the risk of 
exceeding the target cost.  This assumes there was fenceline contact between the breeding herd 
and the stockers during a time frame when PI animals could be created.  In U.S. beef production 
systems, stockers may be imported at relatively high numbers to take advantage of additional 
grazing or as a market risk management option.  The number of stockers modeled here represents 
approximately 1 truckload of stockers and was meant to be representative of the lower end of 
potential import volume.  Some combination of vaccinating and testing (strategies U-Z), was 
always dominant if stockers and non-pregnant heifers were imported.  If imported heifers were 
pregnant, the preferred combination of vaccinating and testing always included testing imported 
calves and calves of pregnant imports (strategies Y or Z) in medium and large herds.  In the 400-
head herd importing stockers and pregnant heifers, dominance was observed for strategy Z, 
which adds stocker testing to strategy Y.  Testing stockers decreased the probability of a high-
cost outbreak, though not the median cost of BVDV (Table 5), in large herds by decreasing the 
risk of importing PI stockers (Smith et al. 2009).  However, the cost of testing stockers (strategy 
R) was greater than the target value for 50-head herds and the cost of combining stocker testing 
with the other testing strategies (strategies T and Z) was greater than the target value for 100-
head herds.  Because the base cost of testing stockers is so high, it was only included in the 
lowest-risk options for 400-head herds.  If management and facilities allow, the most cost 
effective management of the risk due to stockers may be to assure that there was no contact 
between the imported stockers and the breeding herd, which would be comparable to the herds in 
these results that did not import stockers. 
In the absence of stockers, vaccination of breeding animals as a single biosecurity 
practice (strategy N) only slightly decreased the risk of exceeding economic targets.  Instead, 
testing-based strategies, with vaccination, became co-dominant.  If pregnant heifers were 
imported, large and medium-sized herds required testing of imported calves in combination with 
other strategies because more animals were imported than in small herds, increasing the risk of 
introducing a PI animal.  Based on the results of this model, it would be advisable for herds in 
which the majority of risk is based on importation of animals to the breeding herd, rather than 
stockers, to prioritize appropriate testing strategies.  Herds that have contact with other herds at 
fencelines or in communal pastures have introduction risk that cannot be controlled by testing, 
requiring a vaccination strategy.  
In the 50- and 100-head herds, strategies combining vaccination or large amounts of 
testing (strategies T and Z) cost more than the target value specified.  While these strategies may 
decrease the risk of introducing and spreading BVDV in the herd, they do not appear to be cost-
effective in the long term.  This finding agrees with Nickell et al. (2011), which found that 
whole-herd testing strategies had negative value if herd prevalence was low.  A more judicious 
use of targeted testing and vaccination, was preferable from an economic standpoint.  This 
decision will be driven by the individual producer’s risk aversion. 
The results presented in Table 4, although useful, were limited to a single target value.  
While this is useful for decision making if the target value is known, different producers may 
have different levels of acceptable risk.  Therefore, different producers will likely prefer to make 
decisions based on alternative target values.  Figure 1 shows that different target values will 
provide different results.  It should be noted that the lowest variation in cost was always in the 
scenario with the most interventions (Table 5), but that this scenario only had the lowest median 
cost in large herds importing either pregnant heifers or stockers (A3P,A3N and A4P).  This 
shows that a high number of interventions would be successful in controlling an outbreak should 
it occur, but that the base cost may be too high to be economically justifiable for all but the 
largest herds.  However, the risk-averse producer may prefer to select a control program with a 
large base cost, within reason, in exchange for more regularity in costs in the long term. 
The results presented here are specific to the herd profiles used to obtain them and 
indicate that the most cost effective biosecurity plan should be designed for the specific risks of 
the herd.  We elected to include herd size, heifer imports and stocker number of imports as fixed 
values because they represent herd level decisions related to resource availability and 
management preference rather than random variables. Herd size is a relatively fixed value over 
time for most herds, heifer replacement rates are correlated to herd size and stocker imports are a 
management strategy that is constrained by resource availability.  The groups and management 
decisions included were meant to represent the range of size and management practice in US 
Cow-calf herds to provide a broad estimate of effects.  While generalizations may be made, it is 
preferable to model specific herd practices on an individual basis.  However, the results 
presented here suggest that, for herds with modest import rates, strategic testing of imports was 
the most cost-effective way to exclude BVDV and control losses.  For herds with some level of 
uncontrolled risk, such as exposure to stockers or neighboring herds, vaccination of the breeding 
herd may be a cost-effective addition to strategic testing strategies.   
The global sensitivity analysis of the integrated model (Table 6) provided some intriguing 
results.  In herds with little to no control or biosecurity, the cost of BVDV was directly and 
strongly related to the number of lost calves (abortions and mortality) and the price those calves 
would have brought.  In herds with large amounts of testing, however, the cost of testing was the 
most influential distribution, and the cost of vaccination was influential when animals were 
vaccinated.  When testing strategies were used, a $2.16 increase in the cost of a test (increasing 
the test cost from its 5
th
 percentile to its 95
th
 percentile) resulted in a 43% increase in the mean 
cost of a herd testing all imported animals, while the same increase resulted in 40% cost increase 
in a herd that added vaccination of all adult animals to the control program and a 36% cost 
increase in a herd testing all imports except stockers that also relied on vaccination.  The impact 
of increasing the cost of vaccine by $0.67 (increase from 5
th
 to 95
th
 percentile) was smaller, but 
that was due to the fact that more animals were tested than were vaccinated with the biosecurity 
strategy used, as increases in control costs were the only difference observed (data not shown).  
These findings would indicate that the cost of the test and the vaccine could have a substantial 
impact on the choice of biosecurity strategy.   
The local sensitivity analysis shows that, in the absence of testing, the effect of changing 
the vaccine efficacy alone was far greater than the effect of changing the vaccine price alone, 
such that a vaccine with a higher efficacy and a higher price would still be cost-effective.  In 
combination with testing, however, vaccine efficacy had little effect such that increasing the cost 
of the vaccine in order to increase the vaccine efficacy would not be cost-effective.  The vaccine 
efficacy distribution also incorporated substantial natural variability.  Published estimates of 
vaccine efficacy in preventing PIs vary considerably.  Some of this variability may be due to 
differences between vaccines, but some may also be due to differences in the specifics of the 
trials related to cattle factors and viral challenge factors.  In a production setting, additional 
variability exists due to vaccine handling and management of cattle that may affect their ability 
to mount an effective immune response.  This model attempts, with a wide distribution, to 
capture some of the variation seen with different vaccines, their performance against different 
strains of BVDV, and the management factors that affect their efficacy.   
The biological variable shown to be most influential was the abortion risk, as abortions 
were among the most costly of outcomes and, like vaccine efficacy (as discussed above), the 
abortion risk can also vary widely between strains.  The TI mortality risk was also rather 
influential in the absence of control.  Surveyed experts believed that TI mortality risks were 
generally modest, based on their personal experience in cow-calf herds experiencing outbreaks,  
but high mortality risks in calves have been observed.  This phenomenon may be due to 
variability seen in BVDV strains and herd susceptibility, so these distributions were 
appropriately wide and, therefore, influential in the model.  The TI mortality distribution was 
more influential when no control strategy was used (strategy M) in a large herd with a greater 
potential number of calves affected; this herd would experience more TIs over 10 years simply 
due to the number of animals at risk, which would explain the greater influence of the TI 
mortality risk.  If animals were tested, the effect of biological variables was substantially 
decreased, as testing would decrease the risk of introducing an infected animal to the herd. 
This model predicts that a combination of vaccination and testing is most likely to prevent large 
outbreak costs due to BVDV in cow-calf herds, but that viruses with a high abortion risk and 
tests with a high unit cost could greatly increase the mean cost.  These results should be useful to 
cow-calf herds interested in comparing the potential economic consequences with the risk of 
BVDV outbreaks under alternative common management protocols. 
This model assesses the impact of planned strategies implemented over a long range planning 
horizon.  We believe this approach has value particularly for the herd production practices 
modeled where cattle are imported each year and supports that these planned strategies can be 
economic in decreasing costs over the 10 year planning horizon.  Alternate surveillance 
strategies could be used such as passive surveillance of production and disease or targeted 
testing.  Passive surveillance strategies monitoring, for example pregnancy rates or increased calf 
morbidity or mortality would be difficult to implement in the model without including other 
causes of these herd problems to account for the rate of false positive signals (for BVD).  Test 
based surveillance and triggers for more extensive testing and interventions could be considered 
and implemented in future models and may be more cost effective particularly in lower risk 
herds with fewer animals imported. 
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 Table 1: Distributions used in economic analysis of biosecurity strategies for bovine viral 
diarrhea virus in a cow-calf herd 
Parameter Description Distribution Reference(s) 
Young calf and fetal 
prevalence 
Normal(0.59%,0.08%), 
Truncate(0,1) 
(Caldow et al., 1993; 
Wittum et al., 2001; 
Cleveland, 2003) 
Youngstock prevalence 
(stockers, bulls) 
Normal(0.47%, 0.11%)  
Truncate (0, 1) 
(Howard et al., 1990; Taylor 
et al., 1995; Fulton et al., 
2000; Givens et al., 2003; 
Cleveland, 2003; Loneragen 
et al., 2005; Gnad et al., 
2005)  
Heifer prevalence If source herd was positive 
(from a binomial based on herd 
prevalence), youngstock 
prevalence/herd prevalence 
Expert survey
*
 
Cow prevalence Normal (0.07%, 0.04%)  
Truncate (0, 1) 
(Smith et al., 2007) 
Herd prevalence Normal (10.16%, 2.7%)  
Truncate (0, 1)    
(Wittum et al., 1997; 
Wittum et al., 2001) 
Probability of fenceline 
infection 
Pert (6%,47%,83%) Expert survey
*
 
R0
@
-PI
^
 animal present Pert (5,7,12) Personal opinion 
R0
@
-no PI
^
 animal present Pert (1.2,3,5) Personal opinion 
Test sensitivity Pert (89.6%,97.9%,99.5%) 
 
(Frey et al., 1991; Mignon et 
al., 1992; Haines et al., 
1992; Ellis et al., 1995; 
Sandvik and Krogsrud, 
1995; Brinkhof et al., 1996; 
Deregt and Prins, 1998; 
Graham et al., 1998; 
Schreiber et al., 1999; Saliki 
et al., 2000; Plavsic and 
Prodafikas, 2001; Grooms 
and Keilen, 2002; Deregt et 
al., 2002; Ozkul et al., 2002; 
Kim and Dubovi, 2003; 
Cornish et al., 2005; Walz et 
al., 2005; Kuhne et al., 
2005; Kennedy et al., 2006) 
Vaccine Efficacy Pert (0.42,0.845,1) (Brownlie et al., 1995; 
Cortese et al., 1998; Patel et 
al., 2002; Zimmer et al., 
2002; Dean et al., 2003; 
Kovacs et al., 2003; 
Fairbanks et al., 2004; 
Brock et al., 2006; Ficken et 
al., 2006a; Ficken et al., 
2006b) 
Abortion Risk Pert (1.7%,10%,25%) Expert survey
*
 
TI
$
 Mortality Risk 
(the proportion of all TI
$
 
calves that will die in one 
year due to BVDV) 
Pert (1%,11%,32%) Expert survey
*
 
TI
$
 Morbidity Risk 
(the proportion of TI
$
 calves 
that will become morbid due 
to BVDV) 
Pert (2%,24%,69%) Expert survey
*
 
weight lost by morbidity (kg) Normal (15.9, 3.5) Truncate (0, 
) 
(Wittum et al., 1994) 
PI
^
 mortality  
(the proportion of all PI
^
 
calves that will die in one 
year due to BVDV) 
Pert (11%,44%,74%)  Expert survey
*
 
PI
^
 Morbidity Risk 
(the proportion of PI
^
 calves 
that will become morbid due 
to BVDV) 
Pert (23%,44%,64%) Expert survey
*
 
Probability of a PI
^
 fetus due 
to infection during the risk 
period (vertical transmission 
risk) 
Normal (82%, 8.2%)  
Truncate (0, 1) 
(Stokstad and Loken, 2002) 
Probability of an EED
!
 due to 
infection during the risk 
period 
Normal (16%,8%)  
Truncate (0,1)) 
(McGowan et al., 1993a; 
McGowan et al., 1993b) 
Probability of a deformed 
calf due to infection during 
Pert (3.2%,13.6%,30%) Expert survey
*
 
the risk period 
Duration of immunity from 
transient infection 
50% for 1 year, 50% for 2 years Personal opinion 
Weaning weight kg (steers) Normal (272,4.5) for 60 day 
breeding seasons 
Normal (263,4.5) for 100 day 
breeding seasons 
Expert consensus based on 
available production data 
sources (Kansas Farm 
Management Association 
Enterprise data, and regional 
Standardized Performance 
Analysis data) 
Weaning weight kg (heifers) Normal (268,4.5) for 60 day 
breeding seasons 
Normal (259,4.5) for 100 day 
breeding seasons 
Price of 227-272 kg heifers 
($/45 kg) 
Normal (146.50, 14.67) with 
correlation of 0.9 between all 
prices in all years 
 
Price of 227-272 kg steers 
($/45 kg) 
Normal (164.03, 16.96) with 
correlation of 0.9 between all 
prices in all years 
http://www.agmanager.info/
livestock/marketing/databas
e/default.asp - Monthly 
Feeder Cattle and Western 
Kansas Slaughter Cattle 
Price of 272-318 kg heifers 
($/45 kg) 
Normal (137.77, 12.93) with 
correlation of 0.9 between all 
prices in all years Prices  Accessed August 13, 
2013 
Price of 272-318 kg steers 
($/45 kg) 
Normal (149.75, 14.35) with 
correlation of 0.9 between all 
prices in all years 
Cost of test (/head) Pert (2.5,4,6) Survey
#
 
Cost of vaccination (/head) Uniform (0.75,1.5) Survey
&
 
Cost of labor ($/hour) Pert (7.25,9,12) Expert opinion 
Treatment costs (/calf) Pert (4,10,15) Expert survey
&
 
*
 A written survey of 5 veterinarians with field and research experience with BVDV. 
+
 An oral survey of 5 veterinarians with field research with BVDV. 
#
 A survey of regional diagnostic laboratories and private laboratories. 
&
A survey of online distributor prices. 
^
 PI - persistent infection 
$
 TI - Transient infection  
@
 R0 – Basic reproductive number of new cases arising from an infectious case in a susceptible 
population  
!
 EED - Early Embryonic Death 
Table 2: Herd profiles used in analysis of a model for bovine viral diarrhea virus in a cow-calf 
herd.  Import numbers represent annual imports; stockers are imported to adjacent fields, where 
they represent a fenceline contact risk. 
 
Herd 
number 
of 
breeding 
females 
number and 
type of heifers 
imported 
number of bulls 
imported 
number 
of calves 
imported 
number 
of 
stockers 
imported 
A3P 400 60 pregnant 4 0 100 
A3N 400 60 non-pregnant 4 0 100 
A4P 400 60 pregnant 4 0 0 
A4N 400 60 non-pregnant 4 0 0 
B3P 100 15 pregnant 1 0 100 
B3N 100 15 non-pregnant 1 0 100 
B4P 100 15 pregnant 1 0 0 
B4N 100 15 non-pregnant 1 0 0 
C3P 50 8 pregnant 
1 every other 
year 
0 100 
  
 
 
C3N 50 8 non-pregnant 
1 every other 
year 
0 100 
C4P 50 8 pregnant 
1 every other 
year 
0 0 
C4N 50 8 non-pregnant 
1 every other 
year 
0 0 
Table 3: Biosecurity and control strategies used in analysis of a model for bovine viral diarrhea 
virus in a cow-calf herd; in strategies involving testing of at least one category, all animals in the 
category were tested 
 
Strategy 
Vaccination 
of breeding 
animals 
Test 
Imported 
Adults
* 
Test Imported 
Calves and Calves 
of Pregnant 
Imports 
Test all calves 
before 
breeding 
Test 
Imported 
Stockers 
M      
N X     
O  X    
P   X   
Q    X  
R     X 
S  X X X  
T  X X X X 
U X X    
V X  X   
 *
adults refers to breeding animals: heifers, cows, and bulls 
 
 
 
 
 
W X   X  
X X    X 
Y X X X X  
Z X X X X X 
Table 4: Risk analysis model-predicted probability (and 95% confidence interval) of exceeding target costs due to bovine viral 
diarrhea virus over 10 years in cow-calf herds.  Herd profiles are defined in Table 2 and strategies are defined in Table 3.  The target 
cost was $40,000 for all A herds, $7,500 for all B herds, and $2,500 for all C herds. 
S
tr
a
te
g
y
 
Herd profile 
A3P A3N A4P A4N B3P B3N B4P B4N C3P C3N C4P C4N 
M 99% 
(98-
100%) 
82%  
(80-
84%) 
98%  
(98-
99%) 
73%  
(71-
75%) 
88%  
(87-
89%) 
72%  
(70-
74%) 
81%  
(80-
82%) 
57%  
(55-
59%) 
76%
 
 
(74-78) 
62% 
 
(60-
64%) 
61% 
 
(59-
63%) 
40%
  
(38-
42%) 
N 
97%  
(96-98%) 
71%  
(69-
73%) 
96%  
(95-
97%) 
67%  
(65-
69%) 
76%  
(74-
78%) 
54%  
(52-
56%) 
72%  
(70-
74%) 
47%  
(45-
49%) 
59%
 
 
(57-61% 
41% 
 
(39-
43%) 
50% 
 
(48-
52%) 
29% 
 
(27-
31%) 
O 99%  
(98-
50%  
(48-
98%  
(98-
27%  
(25-
87%  
(86-
51%  
(49-
80% 
(79-
25%  
(23-
76%  
(74-
55%  
(53-
60%  
(58-
26%  
(24-
100%) 52%) 99%) 29%) 88%) 53%) 81%) 27%) 78%) 57%) 62%) 28%) 
P 
63%  
(61-65%) N/A 
47%  
(45-
49%) N/A 
55%  
(53-
57%) N/A 
31%  
(29-
33%) N/A 
57%
  
(55-
59%) N/A 
30%
  
(28-
32%) N/A 
Q 
77%  
(75-79%) 
74%  
(72-
76%) 
75%  
(73-
77%) 
71%  
(69-
73%) 
65%  
(63-
67%) 
59%  
(57-
61%) 
55%  
(53-
57%) 
50%  
(48-
52%) 
74% 
 
(72-
76%) 
66%
  
(64-
68%) 
57% 
 
(55-
59%) 
42%
  
(40-
44%) 
R 
99%  
(98-99%) 
75%  
(73-
77%) N/A N/A 
82%  
(81-
83%) 
59%  
(57-
61%) N/A N/A 100% 
 
100%  N/A N/A 
S 17%  
(15-19%) 
24%  
(22-
7%  
(6-8%) 
15%  
(13-
30%  
(28-
31%  
(29-
13%  
(12-
14%  
(13-
74% 
c
 
(72-
73% 
(71-
51%  
(49-
50%  
(48-
26%) 17%) 32%) 33%) 14%) 15%) 76%) 75%) 53%) 52%) 
T 
9%  
(8-10%) 
16%  
(14-
18%) N/A N/A 100%
 
 100%
 
 N/A N/A 100%
 
 100%
 
 N/A N/A 
U 
96%  
(95-97%) 
24%  
(22-
26%) 
95%
 
 
(94-
96%) 
15%  
(13-
17%) 
74%  
(72-
76%) 
24%  
(22-
26%) 
69%  
(67-
71%) 
11%  
(10-
12%) 
59% 
b
 
(57-
61%) 
30%  
(28-
32%) 
49%  
(47-
51%) 
13%  
(12-
14%) 
V 
42%  
(40-44%) N/A 
35%  
(33-
37%) N/A 
29%  
(27-
31%) N/A 
18%  
(17-
19%) N/A 
33%
 
 
(31-
35%) N/A 
17%
  
(16-
18%) N/A 
W 72%  
(70-74%) 
70%  
(68-
71%  
(69-
69%  
(67-
57%  
(55-
51%  
(49-
51%  
(49-
47%  
(45-
97% 
 
(96-
97%
  
(96-
96% 
 
(95-
95% 
 
(94-
Strategies within columns with overlapping 95% CI are not significantly different 
Herd Profiles within rows and herd size group with overlapping 95% CI are not significantly different 
Numbers in bold are the lowest risk option for that column.
72%) 73%) 71%) 59%) 53%) 53%) 49%) 98%) 98%) 97%) 96%) 
X 
97%  
(96-97%) 
68%  
(66-
70%) N/A N/A 
78%  
(77-
79%) 
52%  
(50-
54%) N/A N/A 100%  100%  N/A N/A 
Y 
7%  
(6-8%) 
15%  
(14-
16%) 
3%  
(2-4%) 
11%  
(10-
12%) 
17%  
(16-
18%) 
18%  
(16-
19%) 
7%  
(6-8%) 
9%  
(8-10%) 100%  100%  100%  100%  
Z 
4%  
(3-5%) 
12%  
(11-
13%) N/A N/A 100%
 
 100%
 
 N/A N/A 100%  100%  N/A N/A 
 Table 5: Risk analysis model-predicted median (95% prediction interval) costs (reported as $1,000) due to bovine viral diarrhea virus 
over 10 years in cow-calf herds.  Herd profiles are defined in Table 2 and strategies are defined in Table 3.   
S
tr
a
te
g
y
 
Herd profile 
A3P A3N A4P A4N B3P B3N B4P B4N C3P C3N C4P C4N 
M 209 
(83-310) 
134 
(0-270) 
207 
(72-309) 
118 
(0-266) 
28 
(0-61) 
21 
(0-54) 
26 
(0-60) 
15 
(0-50) 
9 
(0-24) 
6 
(0-20) 
7 
(0-22) 
0 
(0-17) 
N 136 
(31-221) 
76 
(5-188) 
135 
(24-220) 
71 
(4-185) 
16 
(1-40) 
10 
(1-33) 
15 
(1-39) 
5 
(1-31) 
4 
(1-13) 
1 
(1-11) 
3 
(1-13) 
1 
(1-10) 
O 210 
(81-313) 
40 
(3-241) 
207 
(69-312) 
3 
(2-223) 
28 
(1-61) 
9 
(1-42) 
26 
(1-60) 
1 
(1-34) 
9 
(1-24) 
4 
(1-18) 
6 
(0-22) 
0 
(0-14) 
P 95 
(2-261) N/A 
26 
(2-250) N/A 
11 
(1-45) N/A 
1 
(1-36) N/A 
4 
(1-19) N/A 
0 
(0-15) N/A 
Q 
101 
(18-221) 
99 
(16-222) 
99 
(17-220) 
97 
(15-
219) 
14 
(4-45) 
13 
(4-44) 
10 
(4-43) 
7 
(4-43) 
4 
(2-16) 
3 
(2-16) 
3 
(2-16) 
2 
(2-15) 
R 211 
(78-314) 
123 
(4-271) N/A N/A 
30 
(4-64) 
20 
(4-55) N/A N/A 
11 
(4-27) 
5 
(4-21) N/A N/A 
S 
21 
(18-79) 
21 
(18-126) 
20 
(18-61) 
20 
(18-
120) 
6 
(4-20) 
6 
(4-24) 
5 
(4-15) 
5 
(4-21) 
3 
(2-10) 
3 
(2-11) 
3 
(2-8) 
2 
(2-9) 
T 24 
(22-67) 
24 
(21-124) N/A N/A 
9 
(8-20) 
9 
(8-26) N/A N/A 
7 
(6-12) 
7 
(6-13) N/A N/A 
U 132 
(26-223) 
8 
(7-149) 
130 
(20-222) 
8 
(7-139) 
15 
(2-38) 
2 
(2-22) 
14 
(2-37) 
2 
(2-18) 
4 
(1-14) 
1 
(1-8) 
2 
(1-12) 
1 
(1-7) 
V 22 
(7-170) N/A 
8 
(7-165) N/A 
2 
(2-25) N/A 
2 
(2-22) N/A 
1 
(1-9) N/A 
1 
(1-8) N/A 
W 
66 
(21-150) 
64 
(20-148) 
65 
(20-150) 
63 
(20-
147) 
9 
(5-30) 
8 
(5-29) 
8 
(5-29) 
6 
(5-28) 
3 
(2-11) 
3 
(2-11) 
3 
(2-10) 
3 
(2-10) 
X 139 
(29-224) 
75 
(9-190) N/A N/A 
19 
(5-43) 
10 
(5-36) N/A N/A 
7 
(5-17) 
5 
(5-14) N/A N/A 
Y 24 
(22-51) 
24 
(22-78) 
24 
(22-44) 
24 
(22-77) 
6 
(6-13) 
6 
(6-16) 
6 
(5-11) 
6 
(5-15) 
3 
(3-7) 
5 
(3-7) 
3 
(3-6) 
3 
(3-6) 
Z 28 28 N/A N/A 10 10 N/A N/A 7 7 N/A N/A 
  
Numbers in bold were the lowest median cost for that column. 
Numbers in italics were the lowest variability for that column.
(26-50) (25-81) (9-15) (9-19) (7-10) (7-11) 
 
Table 6: Correlation coefficient from a global sensitivity analysis of the 10-year cost of BVDV 1 
in a 400-head cow-calf herd importing 60 pregnant heifers, 4 bulls, and 100 stockers annually in 2 
5 control scenarios. Values in bold were significantly correlated with the mean 10 year cost of 3 
BVDV.   4 
Input Parameter 
Correlation coefficient 
M
1 
N
2 
T
3 
Y
4 
Z
5 
Abortion Risk 0.58 0.51 0.00 0.01 0.01 
Price of 227-272 kg steers 0.30 0.25 0.00 -0.02 -0.01 
Price of 227-272 kg heifers 0.30 0.25 0.00 -0.02 -0.01 
Price of 272-318 kg steers 0.29 0.24 0.01 -0.01 0.01 
Price of 272-318 kg heifers 0.29 0.24 0.01 -0.01 0.01 
TI
$
 Mortality Risk 0.25 0.17 0.06 0.06 0.03 
PI
^
 Mortality Risk 0.08 0.05 0.00 0.01 0.01 
Calf prevalence 0.06 0.07 0.02 0.03 0.02 
R0
@
 for PI
^
 animals -0.06 0.02 -0.01 -0.02 -0.02 
PI
^
 Fetal Mortality Risk 0.05 0.03 0.01 -0.01 0.00 
TI
$
 Morbidity Risk 0.04 0.03 0.03 0.02 0.02 
Herd prevalence 0.04 0.05 0.06 0.02 0.03 
Treatment costs/morbid calf ($) 0.04 0.05 0.03 0.01 0.01 
Weight lost by Morbidity (kg) 0.04 0.02 0.02 0.01 0.02 
Prevalence in cows 0.02 0.01 0.03 0.03 0.03 
Vaccine Efficacy 0.01 -0.21 0.02 -0.05 -0.05 
Probability of infection from fenceline contact -0.01 -0.02 0.10 0.11 0.07 
Fetal Malformation Risk -0.01 -0.01 0.00 0.00 0.01 
R0
@
 for TI
$
 animals -0.01 0.01 0.03 0.09 0.04 
Unit cost of vaccination ($) -0.01 0.01 0.03 0.23 0.23 
Test Sensitivity 0.01 0.01 -0.05 -0.02 -0.04 
Risk of Early Embryonic Death 0.01 0.00 0.01 0.02 0.01 
Unit cost of test ($) 0.01 -0.02 0.78 0.72 0.86 
Labor costs ($/hour) 0.00 -0.01 0.02 0.03 0.03 
Stocker prevalence 0.00 0.00 0.00 0.03 -0.01 
1
 No biosecurity or control programs for BVDV 5 
2
 Annual vaccination of all adult animals 6 
3 
Testing all imports (including stockers) and calves of imports and testing all calves before 7 
breeding 8 
4
 Testing imports to the breeding herd (excluding stockers) and calves of imports and testing all 9 
calves before breeding, with annual vaccination of all adult animals 10 
5 
Testing all imports (including stockers) and calves of imports and testing all calves before 11 
breeding, with annual vaccination of all adult animals 12 
^
 PI - Persistent infection 13 
$
 TI - Transient infection  14 
@
 R0 – Basic reproductive number of new cases arising from an infectious case in a susceptible 15 
population  16 
17 
 18 
Table 7: Results of a local sensitivity analysis showing the proportional change in the mean 10-19 
year cost of BVDV in a 400-head cow-calf herd importing 60 pregnant heifers, 4 bulls, and 100 20 
stockers annually in 5 control scenarios.  Proportional changes were calculated taking the 21 
difference in mean costs for the scenario with the input parameter of interest fixed at the 95
th
 and 22 
5
th
 percentiles and dividing by the mean cost for the scenario with all parameters allowed to vary 23 
within their distributions. 24 
Input Parameter Range Used 
Proportional Change 
M
1 
N
2 
T
3 
Y
4 
Z
5 
Abortion Risk (/year) 0.0448-0.1866 0.70 0.73 0.15 0.13 0.05 
Price of 227-272 kg steers (/45kg) $99.30-$155.10 
0.41 0.39 0.07 0.05 0.02 
Price of 227-272 kg heifers 
(/45kg) 
$92.20-$140.50 
Price of 272-318 kg steers (/45kg) $95.70-$142.90 
Price of 272-318 kg heifers 
(/45kg) 
$91.90-134.40 
TI
$
 Mortality Risk (/year) 0.0425-0.229 0.31 0.26 0.04 0.03 0.01 
Vaccine Efficacy 0.612-0.952 N/A -0.33 N/A -0.05 -0.04 
Unit cost of test ($) $3.04-$5.20 N/A N/A 0.43 0.36 0.40 
Unit cost of vaccine ($) $0.79-$1.46 N/A 0.02 N/A 0.10 0.09 
1
 No biosecurity or control programs for BVDV, mean cost = $205,429 25 
2
 Annual vaccination of all adult animals, mean cost = $133,445 26 
3 
Testing all imports (including stockers) and calves of imports and testing all calves before 27 
breeding, mean cost = $27,632 28 
4
 Testing imports to the breeding herd (excluding stockers) and calves of imports and testing all 29 
calves before breeding, with annual vaccination of all adult animals, mean cost = $26,499 30 
5 
Testing all imports (including stockers) and calves of imports and testing all calves before 31 
breeding, with annual vaccination of all adult animals, mean cost = $29,254 32 
$
 TI - Transient infection  33 
 34 
 35 
36 
Figure 1  Descending Cumulative Probability curves for 10-year disease loss and control costs 37 
for 5 different control strategies used in the sensitivity analysis (each represented by a different 38 
line color and style).  a) 400 head herd importing 60 pregnant heifers and 100 stockers; b) 400 39 
head herd importing 60 non-pregnant heifers and no stockers 40 
 41 
a 42 
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b 46 
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